Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Dexamethasone Showed Better Outcomes Than Triamcinolone For Managing Neuropathic Pain Syndromes Among Cervical Disc Herniation Patients At 3-Month Follow-Up

Trianggoro Budisulistyo, Endang Kustiowati, Amin Husni, Hexanto Muhartomo, Suryadi, Ria Astari Yudhasyah.




Abstract

Background: Cervical disc herniation (CDH) is the most common cause of radicular pain, which one-third of the population suffered at more than 6 months. Epidural steroid injection is quite commonly performed in this disorder, whether in acute or chronic phases. There are two steroid drugs commonly used: triamcinolone and dexamethasone, which both observed efficacies. This study is aimed at comparing both to neuropathic pain improvement.
Methods: The randomized blinded control trial study was conducted in Dr. Kariadi Semarang in Indonesia. Chronic CDH patients were divided into two groups: Triamcinolone and Dexamethasone, who performed interlaminar cervical epidural injections under fluoroscopic guidance. Our study might run from January 2022 to July 2023, so the PainDETECT scoring was carried out before and 3 Months afterward. Comparison to determine effective therapy using the Mann-Whitney test, and significantly defined p

Key words: Keywords: chronic CDH, neck pain, epidural steroid injection, Dexamethasone, Triamcinolone, Pain DETECT






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.